Transdermal therapeutic patches containing 4-N-butylresorcinol
US9801971B2 · kind B2 · utility
0Cited by
9References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 14, 2010 |
| Grant date | Oct 31, 2017 |
| Priority date | — |
| Expiry date | Jul 14, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2300/404
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Transdermal therapeutic systems that contain 4-n-butylresorcinol as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.